RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression

Continued endocrine therapy is associated with improved survival in patients with breast cancer brain metastases

(2019) Elisabeth Sophie Bergen et al.   CLINICAL CANCER RESEARCH

From latency to overt bone metastasis in breast cancer: Potential for treatment and prevention

(2019) Fernando Salvador et al.   JOURNAL OF PATHOLOGY

IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts

(2018) Carrie D. House et al.   BMC CANCER

Interaction of STAT3 and RelB modulates MMP-1 in colon cancer

(2018) Xue-Feng Jiang et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Challenges and perspectives in the treatment of diabetes associated breast cancer

(2018) Samson Mathews Samuel et al.   CANCER TREATMENT REVIEWS

HZ08 suppresses RelB-activated MnSOD expression and enhances Radiosensitivity of prostate Cancer cells

(2018) Yanyan Zhang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Breast cancer

(2017) Nadia Harbeck et al.   LANCET

Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma

(2016) Federico Rojo et al.   BRITISH JOURNAL OF CANCER

S100A4 Elevation Empowers Expression of Metastasis Effector Molecules in Human Breast Cancer

(2016) Thamir M. Ismail et al.   CANCER RESEARCH

Mechanisms of oestrogen receptor (ER) gene regulation in breast cancer

(2016) J S Carroll   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Carcinoma–astrocyte gap junctions promote brain metastasis by cGAMP transfer

(2016) Qing Chen et al.   NATURE

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

(2016) John G Doench et al.   NATURE BIOTECHNOLOGY

Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway

(2016) P Roy et al.   ONCOGENE

Noncanonical NF-κB Signaling in Health and Disease

(2016) Gökhan Cildir et al.   TRENDS IN MOLECULAR MEDICINE

RelB/NF-κB links cell cycle transition and apoptosis to endometrioid adenocarcinoma tumorigenesis

(2016) Qiu-Lin Ge et al.   Cell Death & Disease

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGF  Signaling Pathway

(2015) X.-Q. Li et al.   CANCER RESEARCH

"Braking" the Cycle of Resistance in Endocrine Therapy for Breast Cancer

(2015) A. DeMichele et al.   CLINICAL CANCER RESEARCH

Centchroman suppresses breast cancer metastasis by reversing epithelial–mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling

(2015) Sajid Khan et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells

(2015) Panagiotis Bouris et al.   MATRIX BIOLOGY

Distinct EMT programs control normal mammary stem cells and tumour-initiating cells

(2015) Xin Ye et al.   NATURE

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

(2014) F. Cardoso et al.   BREAST

Doxorubicin induces drug resistance and expression of the novel CD44st via NF-κB in human breast cancer MCF-7 cells

(2014) XIN JIAN FANG et al.   ONCOLOGY REPORTS

Noncanonical NF- B Signaling Is Limited by Classical NF- B Activity

(2014) C. M. Gray et al.   Science Signaling

Different administration strategies with paclitaxel induce distinct phenotypes of multidrug resistance in breast cancer cells

(2013) Donghai Jiang et al.   CANCER LETTERS

Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8

(2013) Z. C. Hartman et al.   CANCER RESEARCH

The complexity of NF-κB signaling in inflammation and cancer

(2013) Bastian Hoesel et al.   Molecular Cancer

Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells

(2013) M F Kendellen et al.   ONCOGENE

A new role for NFκB in immunosurveillance and its implications for cancer immunotherapy

(2013) Amer A Beg et al.   OncoImmunology

The noncanonical NF-κB pathway

(2012) Shao-Cong Sun   IMMUNOLOGICAL REVIEWS

Cytokine Receptor CXCR4 Mediates Estrogen-Independent Tumorigenesis, Metastasis, and Resistance to Endocrine Therapy in Human Breast Cancer

(2010) Lyndsay V. Rhodes et al.   CANCER RESEARCH

Non-canonical NF-κB signaling pathway

(2010) Shao-Cong Sun   CELL RESEARCH

NF-κB addiction and its role in cancer: ‘one size does not fit all’

(2010) M M Chaturvedi et al.   ONCOGENE

RelB Enhances Prostate Cancer Growth: Implications for the Role of the Nuclear Factor- B Alternative Pathway in Tumorigenicity

(2009) Y. Xu et al.   CANCER RESEARCH

RelB NF- B Represses Estrogen Receptor   Expression via Induction of the Zinc Finger Protein Blimp1

(2009) X. Wang et al.   MOLECULAR AND CELLULAR BIOLOGY

The NF- B Family of Transcription Factors and Its Regulation

(2009) A. Oeckinghaus et al.   Cold Spring Harbor Perspectives in Biology

Shared Principles in NF-κB Signaling

(2008) Matthew S. Hayden et al.   CELL

Prostate carcinoma and radiation therapy: therapeutic treatment resistance and strategies for targeted therapeutic intervention

(2008) TJ FitzGerald et al.   Expert Review of Anticancer Therapy